Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Synergy Pharmaceuticals Inc patents


Recent patent applications related to Synergy Pharmaceuticals Inc. Synergy Pharmaceuticals Inc is listed as an Agent/Assignee. Note: Synergy Pharmaceuticals Inc may have other listings under different names/spellings. We're not affiliated with Synergy Pharmaceuticals Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "S" | Synergy Pharmaceuticals Inc-related inventors


Agonists of guanylate cyclase and their uses

This invention provides novel guanylate cyclase c (gc-c) agonists and their therapeutic use. The agonists may be used either alone or in combination with one or more additional agents.. ... Synergy Pharmaceuticals Inc

Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders

The invention provides novel guanylate cyclase-c agonist peptides and their use in the treatment of human diseases including gastrointestinal disorders, inflammation or cancer (e.g., a gastrointestinal cancer). The peptides can be administered either alone or in combination with an inhibitor of cgmp-dependent phosphodiesterase. ... Synergy Pharmaceuticals Inc

Formulations of guanylate cyclase c agonists and methods of use

The invention provides low-dose formulations of guanylate cyclase-c (“gcc”) agonist peptides and methods for their use. The formulations of the invention can be administered either alone or in combination with one or more additional therapeutic agents, preferably an inhibitor of cgmp-dependent phosphodiesterase or a laxative.. ... Synergy Pharmaceuticals Inc

Formulations of guanylate cyclase c agonists and methods of use

The invention provides low-dose formulations of guanylate cyclase-c (“gcc”) agonist peptides and methods for their use. The formulations of the invention can be administered either alone or in combination with one or more additional therapeutic agents, preferably an inhibitor of cgmp-dependent phosphodiesterase or a laxative.. ... Synergy Pharmaceuticals Inc

Process of preparing guanylate cyclase c agonisys

The invention provides processes of preparing a peptide including a gcc agonist sequence selected from the group consisting of seq id nos: 1-249 described herein.. . ... Synergy Pharmaceuticals Inc

Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders

The invention provides novel guanylate cyclase-c agonist peptides and their use in the treatment of human diseases including gastrointestinal disorders, inflammation or cancer (e.g., a gastrointestinal cancer). The peptides can be administered either alone or in combination with an inhibitor of cgmp-dependent phosphodiesterase. ... Synergy Pharmaceuticals Inc

Compositions useful for the treatment of gastrointestinal disorders

This invention provides novel peptides and methods to prevent, control, and treat an inflammation, cancer and other disorders, particularly of the gastrointestinal tract and the lung by administering at least one agonist of guanalyte cyclase receptor either alone or in combination with a compound selected from i) 5-aminosalicyclic acid (5-asa) or a derivative or a pharmaceutically acceptable salt thereof; ii) mercaptopurine; or iii) an anti-tnf therapy.. . ... Synergy Pharmaceuticals Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Synergy Pharmaceuticals Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Synergy Pharmaceuticals Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###